Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Integration of hepatitis … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR

Artikel i vetenskaplig tidskrift
Författare Simon B. Larsson
Gianluca Tripodi
G. Raimondo
C. Saitta
Gunnar Norkrans
T. Pollicino
Magnus Lindh
Publicerad i Journal of Medical Virology
Volym 90
Nummer/häfte 10
Sidor 1568-1575
ISSN 0146-6615
Publiceringsår 2018
Publicerad vid Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 1568-1575
Språk en
Länkar dx.doi.org/10.1002/jmv.25227
Ämnesord Alu-PCR, hepatocellular carcinoma (HCC), hepatitis B virus (HBV), integration, intrahepatic, human hepatocellular-carcinoma, hbv-dna, liver-disease, human genome, sequences, serum, carcinogenesis, replication, mutations, children, Virology
Ämneskategorier Infektionsmedicin

Sammanfattning

Hepatitis B virus (HBV) infection is the main risk factor for hepatocellular carcinoma (HCC) worldwide. Integration of HBV DNA into the human genome has been found in >80% of HBV-related HCC cases. Some studies have, however, found similar integration patterns in tumorous and nontumorous tissues. Thus, the role of integrations for the development of HCC as well as the rate of integration in different stages of infection remain unclear. The aim of this study was to investigate integrations in patients without HCC, representing different stages of chronic HBV (CHB) infection. Extracted DNA in liver biopsies from 74 patients (one with 2 available biopsies) with CHB infection was analyzed by Alu-PCR. Amplicons were further analyzed by Sanger sequencing. Integration was detected in 39 biopsies (52%) as an amplicon containing both human and HBV sequences by Alu-PCR with one primer targeting a region in the HBV genome. Integrations were found in patients representing the different stages of CHB infection. A majority of the HBV sequences were located upstream or downstream of nucleotide position 1820, which previously has been identified as a common breakpoint in the HBV genome in integrated sequences. Approximately 60% of the HBV integrations were found in noncoding regions of the human genome. Integrations of HBV DNA into the human genome is an event frequently found in mild phases of chronic hepatitis.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?